IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL

Condition:   Primary Central Nervous System Lymphoma Intervention:   Drug: IBER salvage chemotherapy followed by ibrutinib maintenance therapy Sponsor:   Deok-Hwan Yang Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials